the functional roles and pharmacological relevance of each OATP member.
In liver, OATP-B (SLC21A9), OATP-C (SLC21A6, LST1/OATP2) and OATP8 (SLC21A8) are expressed at the basolateral membrane (Kullak-Ublick et al., 2001; König et al., 2000a König et al., , 2000b . Among them, OATP-C and OATP8 exhibit specific expression in liver, while OATP-B is expressed in several tissues, including small intestine and liver (Tamai et al., 2000a; Kullak-Ublick et al., 2001) . Compared with OATP-C and OATP8, which accept various anionic compounds as substrates, OATP-B has a higher substrate specificity, but as well as transporting the physiological substrates estrone-3-sulfate and dehydroepiandrosterone sulfate, it also mediates the uptake of the xenobiotic sulfobromophthalein (BSP) (Tamai et al., 2000a (Tamai et al., , 2001a Kullak-Ublick et al., 2001) . Since substrates of OATP-B overlap with those of other OATPs, the role of OATP-B in liver is currently uncertain. Furthermore, it is known that mRNAs of OATP-B, OATP-D (SLC21A11) and OATP-E (SLC21A12) are expressed in human intestine (Tamai et al., 2000a) , whereas their roles remain to be clarified. In rat, it was reported that Oatp3 was localized at the apical membrane of intestinal epithelial cells (Walters et al., 2000) . Recently, it was reported that fruit juices decreased the absorption of the antihistamic drug fexofenadine in human, and fexofenadine might be absorbed via intestinal OATP transporters (Dresser et al., 2002) . These reports suggested that members of JPET #51300, 6 the OATP family might mediate absorption of anionic compounds, including both physiological and xenobiotic compounds, in human small intestine.
The 3-hydroxy-3-methylglutaryl CoA (HMG-CoA) reductase inhibitor pravastatin is a water-soluble drug used to treat hypercholesterolemia. It shows a more selective pharmacological effect on liver compared with more lipid-soluble HMG-CoA reductase inhibitors, and this tissue-selectivity may be ascribed to selective tissue distribution (Koga et al., 1990) . In spite of the hydrophilicity of pravastatin, it is absorbed to the extent of about 30% after oral administration in healthy volunteers (Singhvi et al., 1990; Pan, 1991) , and we suggested involvement of a pH-dependent transporter in the intestinal apical membrane transport of pravastatin (Tamai et al., 1995a) . One of the liver-specific OATPs, OATP-C, mediates the uptake of pravastatin by human hepatocytes (Hsiang et al., 1999; Nakai et al., 2001 ), while it is not clear whether OATP-B transports pravastatin or not. Accordingly, it is possible that OATP family members expressed in human small intestine may mediate the absorption of pravastatin.
We have previously demonstrated that intestinal apical membranes exhibit carrier-mediated transport activity for several organic anions, including acetic acid (Tsuji et al., 1990; Simanjuntak et al., 1991) , benzoic acid (Tsuji et al., 1994) , lactic acid (Tamai et al., 2000b ), nicotinic acid (Simanjuntak et al., 1990 Tanakanaga et al., 1996 ), pravastatin (Tamai et al., 1995a , and salicylic acid (Tanakanaga et al., 1994) through pH-dependent anion exchange and/or proton-coupled transport mechanisms.
We also showed that organic anion transporters expressed in intestinal epithelial cells, including anion exchanger (AE2) (Yabuuchi et al.,1998) and monocarboxylate transporter (MCT1) (Tamai et al., 1995b (Tamai et al., , 1999 Takanaga et al., 1995) transport some of these organic anions through anion exchange and pH-dependent processes, respectively, while pravastatin was not transported by these transporters. Therefore, it is possible that these transporters play at least a part in the JPET #51300, 7
intestinal absorption of organic anions, and additional transporters may be functional in the intestinal apical membrane (Tamai et al., 2000b) .
Rat Oatp3 is expressed in the intestinal apical membrane (Walters et al., 2000) , and rat
Oatp1 apparently exhibited pH-dependent activity in the transport of BSP and taurocholate (Kanai et al., 1996; Satlin et al., 1997) . Based on these previous observations, it was hypothesized that human OATP-B expressed in small intestine might mediate the intestinal absorption of anionic compounds via a pH-dependent mechanism. Accordingly, in the present study we examined the intestinal subcellular localization and functionality of OATP-B by using a typical substrate, estrone-3-sulfate, and a clinically used drug, pravastatin, as model compounds.
JPET #51300, 9
Laboratories) were used for nuclear staining and fixation of sections, respectively. For immunofluorescence staining, tissue sections were incubated with Alexa Fluoro TM 594 goat anti-rabbit IgG (Molecular Probes, Inc., Eugene, OR), as the secondary antibody, for 30 min after incubation with primary antibody. Then, they were mounted in VECTASHIELD mounting medium with DAPI (Vector Laboratories) to fix the sample and to stain nuclei. The specimens were examined with a CK40-RFL microscope (Olympus, Tokyo, Japan) and the images were captured with a Penguin 150CL (Pixera Corporation, Los Gotos, CA).
Transport Experiments
For the transport experiments using HEK293 cells, the construct pcDNA3/OATP-B was vector alone were used to obtain the background activity (termed mock).
Analytical Methods
Cellular protein content was determined according to the method of Bradford (Bradford, 1976 ) by using a BioRad protein assay kit (Hercules, CA) with bovine serum albumin as the standard. Usually, initial uptake rates were obtained by measuring the uptake at 10 min. The uptake activity of OATP-B by HEK293 cells was evaluated after subtracting the uptake by mock-transfected cells from total uptake by the OATP-B-expressing cells.
All data were expressed as means ± S.E.M., and statistical analysis was performed by using Student's t test. Cell-to-medium ratio was obtained by dividing the uptake amount by the cells by the concentration of test compound in the uptake medium. The criterion of significance was taken to be P <0.05.
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Results

Immunohistochemical Localization of OATP-B in Human Small Intestine
To clarify the role of OATP-B in human small intestine, immunohistochemical analysis was performed using human intestinal tissue slices. Figures . These results clearly demonstrate that OATP-B is localized at the apical membrane of enterocytes in human small intestine.
Effect of pH on [ 3 H]Estrone-3-sulfate Uptake by OATP-B
The effect of pH on the initial uptake of [ higher than that at pH 7.4. Accordingly, it was established that OATP-B shows pH-dependent activity, and the following studies were performed mainly at pH 5.5, which is the physiological luminal surface pH, at which OATP-B shows high transport activity.
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Inhibitory Effects of Various Compounds on OATP-B-Specific Uptake of [ 3 H]Estrone-3-sulfate
To characterize the pH-dependence of transport by OATP-B, we examined the inhibitory effects of various compounds on OATP-B-specific uptake of [ 3 H]estrone-3-sulfate at pH 5.5.
Concentrations of inhibitors were chosen to compare the results in the previous studies on the inhibitory effects on pravastatin uptake examined by rabbit brush-border membrane vesicles (Tamai et al., 1995a) . As shown in Table 1 suggested that OATP-B has higher affinity for relatively bulky anions. The affinity of pravastatin for OATP-B was evaluated in terms of the concentration dependence of the inhibitory effect of pravastatin on the uptake of [ The inhibitory effect was indeed concentration-dependent, and the evaluated IC 50 value was 5.5 ± 1.1 mM.
Time Course of [ 14 C]Pravastatin Uptake by OATP-B
To clarify whether pravastatin is a substrate for OATP-B or not, the uptake of Uptake of [ 14 C]pravastatin by mock-transfected cells at pH 5.5 was also higher than that at neutral pH. Since the pKa value of pravastatin is 4.7, the apparent increase in [ 14 C]pravastatin uptake by mock-transfected cells at acidic pH seems likely to be due to an increase of the nonionic form of pravastatin, leading to increased diffusion according to the pH partition hypothesis, and/or it may reflect the involvement of an unknown pH-dependent transporter.
The absence of pH dependence in estrone-3-sulfate transport by mock-transfected cells shown in figure 2 may be due to the low pKa value (less than 2), which makes the observation of the transport by pH-partition hypothesis difficult, and/or the lack of expression of the pH-dependent transporter for estrone-3-sulfate in mock-transfected HEK293 cells.
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Discussion
Although extensive studies on OATP transporters have identified the presence of large numbers of them in mice, rats and humans, the orthologous molecules among species remain to be fully established. Accordingly, it is important to characterize the physiological roles of each member based on the functional characteristics, tissue expression profiles, and regulation mechanism of expression, and to compare them among transporter molecules. Here, we have further characterized human OATP-B by focusing on its role in the small intestine, since no precise information is available on intestinally expressed OATPs in human, though rat
Oatp3 is expressed at the intestinal epithelial apical membrane (Walters et al., 2000) and the presence of a transport system for pravastatin and fexofenadine, which are substrates of some
OATPs, was suggested in small intestine (Tamai et al., 1995; Dresser et al., 2002) . , 2002) . This differential localization of OATP-B among small intestine, liver and placenta is interesting, because the observation suggests the presence of an organ-specific sorting mechanism. Similarly, one of the OATP superfamily, rat Oatp1, is localized at the apical membrane in kidney and at the basolateral membrane in liver (Bergwerk et al., 1996) .
We showed that OATP-B mediates pH-dependent transport of estrone-3-sulfate and pravastatin (figures 2 and 5), and this is the first experimental demonstration that human OATP has pH-dependent functionality. It was reported that the substrate specificity of OATP-B is narrower than those of OATP-A, OATP-C and OATP8 at neutral pH (Kullak-Ublick et al., 2001). However, OATP-B might show broader substrate specificity at acidic pH, judging from the results for pravastatin in the present study. We previously showed that intestinal apical membranes are equipped with a proton-coupled transport system for pravastatin, using rabbit intestinal apical membrane vesicles (Tamai et al., 1995a) . These observations strongly suggested that OATP-B is involved in the intestinal apical membrane transport of pravastatin. The Km value of pravastatin uptake by the membrane vesicles at pH 5.5 (15.2 mM) (Tamai et al., 1995a) was similar to IC 50 value of pravastatin for the uptake of estrone-3-sulfate by OATP-B (5.5 mM, figure 3 ). Uptake of pravastatin by the membrane vesicles was inhibited by monocarboxylic acids and DIDS, but not by di-or tricarboxylic acids (Tamai et al., 1995a) . In the present study, uptake of estrone-3-sulfate by OATP-B was similarly affected by several monocarboxylic acids, but not by acetic acid, though it showed a tendency to have an inhibitory effect (table 1) . Accordingly, OATP-B has affinity for monocarboxylic compounds, but shows a lower affinity for acetic acid. Phthalic acid, which is a dicarboxylic acid, also showed an inhibitory effect on OATP-B-mediated uptake of JPET #51300, 16 estrone-3-sulfate, although it did not inhibit the uptake of pravastatin by rabbit intestinal apical membrane vesicles (Tamai et al., 1995a) . Therefore, the affinity of OATP-B may depend on the size of compounds rather than the number of carboxylic acid moieties. The inhibitory effect of 1 mM DIDS on OATP-B (8.4 % of control, table 1) is stronger than that observed in rabbit apical membrane vesicles (74.9 % of control) (Tamai et al., 1995a) . Since DIDS is a potent inhibitor of anion exchange rather than proton-gradient-stimulated uptake (Tamai et al., 2000b) , OATP-B might be an anion exchange transporter that shows apparent pH dependence, like rat Oatp1, which shows bicarbonate/anion exchange transport (Satlin et al., 1997) , while further studies would be needed as to whether OATP-B is an anion exchanger or not. Accordingly, OATP-B seems to have similar, though not identical, characteristics to those observed in rabbit intestinal apical membrane vesicles. The difference in the selectivity of inhibitors between OATP-B and rabbit intestinal apical membrane vesicles may be due to the difference of test compounds (estrone-3-sulfate in the present study and pravastatin in the previous rabbit membrane vesicle study), species difference or the presence of other transporter(s) for pravastatin in rabbit small intestine.
Figures 4 and 5 showed that pravastatin was transported at acidic pH by OATP-B. This is the first report that pravastatin is a substrate of a transporter localized at the apical membrane of enterocytes, though OATP-B did not significantly transport pravastatin at neutral pH (figure 5). Accordingly, it is suggested that transport activity of pravastatin may be low at the basolateral membrane of liver or lower part of the intestine, where OATP-B is expressed, because the pH in these regions is not so acidic. In a study of healthy subjects, pravastatin was mainly absorbed from the duodenum (Triscari et al., 1995) , and this report supports the idea that OATP-B plays a role in the intestinal transport of pravastatin.
A recent report suggested that intestinal OATP might be an important determinant of the absorption of the antihistamic drug, fexofenadine (Dresser et al., 2002) . The report showed JPET #51300, 17 that fruit juices decreased the AUC and Cmax of fexofenadine in man after an oral administration (Dresser et al., 2002) . Since the AUC and Cmax of fexofenadine were decreased after administration of antacids, aluminium/magnesium hydroxide (Product information, Aventis Pharma Ltd., Tokyo, Japan), the absorption of fexofenadine also may be regulated by intestinal pH, like that of pravastatin (Tamai et al., 1995) , though there is no information as to whether OATP-B has affinity for fexofenadine or is sensitive to fruit juices.
One report showed that grapefruit juice did not significantly affect the AUC value of pravastatin, despite a tendency to decrease the AUC and Cmax (Lilja et al., 1999) . Further study is needed to clarify the absorption mechanism of pravastatin and fexofenadine.
In conclusion, the present study showed that OATP-B might play a role in the OATP-B cDNA-or mock-transfected cells were preincubated for 20 min at 37°C in the uptake buffer (pH 7.4). Uptake of [ 3 H]estrone-3-sulfate (4.76 nM) was measured for
